SubHero Banner
Text

May 2019

Core topics in this month’s edition include:

  • Tracleer (bosentan) - first time generic
  • Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) - new drug approvals
  • Zolgensma (onasemnogene abeparvovec-xioi) - new drug approval

Download PDF

Text